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Detection of Bartonella henselae and Bartonella quintana
by a simple and rapid procedure using broad-range
peR amplification and direct single-strand sequencing
of part of the 168 rRNA gene
Daniel Goldenberger1} TObias Schmidheini2 and Martin Altwegg1
IDepartment of Medical Microbiology, University of Zurich, Zurich, Switzerland;
2Microsynth GmbH, Balgach, Switzerland
Objective: To detect directly Bartonella hense/ae and Bartonella quintana using culture-independent, molecular
techniques, and to evaluate a simple and rapid procedure that allows uncultivable bacteria to be detected in usually
sterile clinical specimens in a diagnostic laboratory.
Methods: From four clinical specimens proven to contain B. hense/ae (n=3) or B. quintana (n=1) DNA, part of the 16S
rRNA gene was amplified using the polymerase chain reaction (PCR) and broad-range bacterial primers followed by
reamplification and direct. single-strand sequencing. The partial 16S rRNA sequences were compared to reference
sequences in databases.
Results: Similarities between sequences derived from clinical samples and those of B. hense/ae and B. quintana,
respectively, were in the range 98.7-100%, indicating a strong association to the genus Bartonella. Intraspecies sequence
variations within the B. hense/ae sequences were observed.
Conclusions: The method described is a rapid, sensitive and reliable tool to generate partial 16S rRNA sequences of
B. hense/ae and B. quintana directly from normally sterile clinical specimens. It is compatible with adequate prevention
of contamination as is needed for diagnostic purposes, and it possesses the potential to detect other pathogens,
including those as yet unknown.
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INTRODUCTION
The comparison of 165 rRNA sequences is now a
well-known tool for taxonomic and phylogenetic
investigations. Such sequences have been derived
by various methods, including T I-oligonucleotide
cataloguing [1,2], direct sequencing of RNA by using
reverse transcriptase [3] and sequencing of polymerase
chain reaction (PCR)-amplified rRNA genes either
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directly or after cloning the products in a suitable
vector [4,5]. Numerous sequences are filed in different
databases which are accessible via on-line search. In
our diagnostic laboratory we work with broad-range
primers and PCR to amplify bacterial rRNA genes
in usually sterile clinical specimens. This culture-
independent approach provides enormous potential for
the identification of uncultivable microbial pathogens
[6].
Here we describe a simple and rapid procedure for
the direct sequencing ofPCR products amplified with
broad-range primers directed against the 165 rRNA
genes of bacteria applied to culture-negative clinical
specimens previously shown to contain either Bartonella
henselae or Bartonella quintana DNA. This is in contrast
to approaches that required cloning of the PCR frag-
ments into a suitable vector before sequencing [6-10).
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Our procedure is appropriate for diagnostic purposes
and eliminates time-consuming template purification
steps before amplification [11] as well as before the
sequencing reaction. In addition, it is compatible with
the use of dUTP instead of dTTp, for prevention of
carryover contanlination.
MATERIAL AND METHODS
Clinical specimens
Four tissue specimens from four patients with proven
Bartonella infection were used. All specimens were kept
frozen at -20°C until analysis and had previously been
tested with a Bartonella-specific pCR directed against
the putative B. henselae analog of the IurA gene of E.
coli, as described by Anderson et al. [12]. They
contained B. henselae (two lymph nodes, one sub-
cutaneous biopsy) and B. quintana (one subcutaneous
biopsy), respectively [13]. In addition, culture (and
Bartonella-specific pCR) negative tissue specimens and
pyrogen-free water were used as controls.
Extraction of DNA
The DNA in the specimens was extracted as previously
described [11]. Briefly, tissue was suspended in about
two volumes of digestion buffer containing sodium
dodecylsulfate (SDS) and proteinase K and incubated
for 3 h at 55°C with agitation. After heat inactivation
of the proteinase K for 10 min at 95°C, the tubes were
cooled to 4°C and centrifuged for 10 min at 12 OOOg.
Two and 0.2 f.lL of the crude DNA extract were diluted
to 10 f.lL with pyrogen-free water and used directly for
pCR amplification.
PCR amplification and detection
A broad-range pCR amplification system was used as
previously described [14] with several modifications.
Briefly, part of the 16S rRNA gene (corresponding to
positions 8-806 of the Escherichia coli 16S rRNA gene)
was amplified using primers BAKllw (5' -AGTTT-
GATC(A/C)TGGCTCAG-3'; identical to primer
8FpL [15] except for the presence of a mixture of A
and C at position 17 of the E. coli sequence) and primer
PC3mod (5' -GGACTAC(C/T/ A)AGGGTATCTA-
AT-3'), resulting in a fragment of approximately 800
bp. pCR amplification was performed in a volume of
100 f.lL containing 10 mM Tris-HCI, pH 9.0, 50 mM
KCI, 3.5 mM MgCb, 0.1% Triton X-lOO, 2% Tween-
20, 200 f.lM each of dUTp, dCTp, dGTp, dATp, 10
pmol of each primer, 0.5 U uracil-DNA glyocylase
(Epicentre Technologies, Madison, WI), 0.5 U Taq
polymerase (SuperTaq, Labofur, Basel, Switzerland),
and 10 f.lL template. Tween-20 (final concentration 2%)
was added to neutralize SDS, which is inhibitory for
the Taq polymerase [11 J. Pyrogen-free water that had
been shown to be free ofcontaminating DNA was used
throughout this study. To inactivate contaminating
bacterial DNA from other components, the pCR mix
without enzymes and template was exposed to UV
light, as previously described, for 15 min on a
transilluminator (254 nm, 6 x 15 W) [14J. Prior to
amplification, the mixtures were held at 37°C for 10
min to destroy any uracil-containing DNA (carryover
contamination from previous amplifications) by the
activity of uracil-DNA glycosylase. Amplification was
performed on a Gene Amp™ PCR System 9600
(Perkin Elmer, Norwalk, CT) using the following
protocol: 94°C for 5 min, 40 cycles of94 °C for 1 min,
48°C for 1 min and 72 °C for 1 min, followed by 10
min at 72 dc. Samples were then kept at -20°C until
further analysis. Amplified DNA fragments were
separated by agarose gel electrophoresis and stained
with ethidium bromide and visualized under UV light,
Southern-blotted and hybridized with digoxigenin-
labeled BAK533r (5'-TTACCGCGGCTGCTGG-
CAC-3'), a broad-range oligonucleotide correspond-
ing to p515FPL [15] without restriction endonuclease
site and in reverse direction (corresponding to positions
533-515 of the E. coli genome). BAK533r had been
labeled using the DIG Oligonucleotide Tailing Kit™
(Boehringer Mannheim, Germany). The hybrids were
detected by luminescence according to the manu-
facturer's guidelines (Boehringer).
Semi-nested reamplification
Amplicons were reamplified in a semi-nested PCR
assay using primer BAKllwand 5'-biotinylated
BAK533r (see above), resulting in a fragment of about
525 bp. Reamplification was performed in a volume of
100 f.lL containing 10 mM Tris·-HCI, pH 9.0, 50 mM
KCI, 1.5 mM MgCb, 0.1% Triton X-l00, 200 f.lM
each ofdUTp, dCTp, dGTp, dATp, and 5 pmol ofeach
primer. Contaminating bacterial DNA was inactivated
by exposure to UV light for 5 min as described above,
followed by the addition of 1 f.lL of the amplicon
diluted to 10 f.lL with pyrogen--free water as template
and 0.5 U Super'Taq. Reamplification was performed as
follows: 95°C for 5 min, 40 cycles of94 °C for 1 min,
50°C for 1 min and 72 °C for 1 min, and 10 min at
72 dc. Samples were then kept at -20°C. Reamplified
DNA fragments were detected on a 2% agarose gel
(Ultra Pure, BRL, Gaithersburg, MD).
Direct single-strand sequencing
Forty microliters of the biotinylated amplicons was
analyzed with the commercial solid-phase sequencing
kit AutoLoad™ (Pharmacia Biotech, Uppsala, Sweden)
as described by the manufacturer. The sequencing
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primer was fluorescein-labeled BAK11w. Briefly, the
biotinylated amplicon was immobilized on a comb
coated with streptavidin; the non-biotinylated strands
were then removed by alkaline denaturation and
washing. After primer annealing and sequencing
reactions (dideoxy chain termination method) the
combs were loaded on a 6% polyacrylamide gel. The
sequencing fragments were then detected with an ALF
DNA sequencer (Pharmacia Biotech). Before database
analysis, the chromatograms were visually controlled to
ensure that only reliable sequence information was used
for analysis.
Database analysis
The four partial sequences were compared and aligned
to bacterial 16S rRNA gene sequences deposited in
GenBank and EMBL databases using the FASTA, the
FASTA-opt and the PILEUP algorithms from the
Genetics Computer Group (GCG) software package
(Madison, WI) [16].
RESULTS
With each of the four clinical specimens known to
contain either B. henselae or B. quintana, a band of the
expected size was visible after amplifIcation, agarose gel
electrophoresis and staining with ethidium bromide,
whereas no negative control showed any visible signal.
These bands strongly hybridized with the labeled
amplicon-specifIc probe; however, a faint band also
became apparent m all negative controls after
hybridization (data not shown).
For the Bartonella-positive specimens, sequencing
resulted in readable stretches of 276-392 bases in one
single sequencing assay (Table 1). Using the FASTA-
opt algorithm, 100% identity to the reference sequence
Table 1 Similarities (in %) of sequences determined as compared to sequences in the databases GenBank and EMBL
database using FASTA-opt from GCG
% similarity to sequence
Number of M73229 211684' M73228b
Patient Specimen bases readable B. hwselae B. henselae B. quintana
1 Lymph node 392 99.7 98.7
2 Lymph node 276 98.6 99.3
3 Skin biopsy 313 99.0 99.7
4 Skin biopsy 278 100
'Sequence 211684 contains an unspecified nucleotide which is calculated as a mismatch when compared to the sequences analyzed.
b The B. quintana sequences U28268 and M11927 are identical to M73228 in the region compared to the sequence analyzed.
Table 2 Scoring results from the partial 16S rRNA gene sequence from patient 2 (276 bp) containing B. hense/ae DNA and
the most related reference sequences from GenBank and EMBL database using the FASTA-opt algorithm
Scoring values from FASTA
Position Organism Accession no. initn opt % similarity
1 B. henselae 211684 939 1088 99.3
2 B. grahamii 231349 933 1085 99.3
3 B. taylorii 231350 912 1064 98.2
4 B. vinsonU a 231352 908 1062 98.6
5 B. elizabethae L01260 736 1062 98.6
6 B. henselae M73229 908 1062 98.6
7 B. doshiae 231351 898 1050 98.6
8 B. quintanab M73228 898 1050 97.5
9 Wolbachia melophagi X89110 891 1043 97.1
10 B. bacilliformis M65249 887 1034 97.1
11 Bartonella species 269039 753 1028 97.5
12 B. bacilliformis X60042 892 1022 96.8
13 B. vinsonii U26258 890 1012 94.4
14 Phyllobacterium rubiocearum D12790 680 1006 94.9
15 B. vinsonii L35052 882 1004 94.1
16 Rhizobium loti D12791 971 992 94.9
'The B. vinsonii sequences M73230 and L01259 are identical to 231352 in the region compared to the sequence analyzed.
bThe B. quintana sequences U28268 and Ml1927 are identical to M73228 in the region compared to the sequence analyzed.
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1 50
M73229 CTCAGAACGA ACGCTGGCGG CAGGCTTAAC ACATGCAAGT CGAGCGCACT
Patient 1 ACT
Zl1684 AACGA ACGCTGGCGG CAGGCTTAAC ACATGCAAGT CGAGCGCAC.
51 100
M73229 CTTTTAGAGT GAGCGGCAAA CGGGTGAGTA ACGCGTGGGA ATCTACCCAT
Patient 1 CTTTTAGAGT GAGCGGCAAA CGGGTGAGTA ACGCGTGGGA ATCTACCCAT
Zl1684 CTTTTAGAGT GAGCGGCAAA CGGGTGAGTA ACGCGTGGGA ATCTACCCAT
Patient 3 CGTGGGA ATCTACCCAT
Patient 2 AT
101 150
M73229 CTCTACGGAA TAACACAGAG AAATTTGTGC TAATACCGTA TACGTCCT.T
Patient 1 CTCTACGGAA TAACACAGAG AAATTTGTGC TAATACCGTA TACGTCCT.T
Z11684 CTCTACGGAA TAACACAGAG AAATTTGTGC TAATACCGTA TACGTCCTAT
Patient 3 CTCTACGGAA TAACACAGAG AAATTTGTGC TAATACCGTA TACGTCCTAT
Patient 2 CTCTACGGAA TAACACAGAG AAATTTGTGC TAATACCGTA TACGTCCTAT
151 200
M73229 AGGGAGAAAG ATTTATCGGA GATGGATGAG CCCGCGTTGG ATTAGCTAGT
Patient 1 AGGGAGAAAG ATTTATCGGA GATGGATGAG CCCGCGTTGG ATTAGCTAGT
Zl1684 TTGGAGAAAG ATTTATCGGA GATGGATGAG CCCGCGTTGG ATTAGCTAGT
Patient 3 TTGGAGAAAG ATTTATCGGA GATGGATGAG CCCGCGTTGG ATTAGCTAGT
Patient 2 TTGGAGAAAG ATTTATCGGA GATGGATGAG CCCGCGTTGG ATTAGCTAGT
201 250
M73229 TGGTGAGGTA ACGGCTCACC AAGGCGACGA TCCATAGCTG GTCTGAGAGG
Patient 1 TGGTGAGGTA ACGGCTCACC AAGGCGACGA TCCATAGCTG GTCTGAGAGG
Zl1684 TGGTGAGGTA ACGGCTCACC AAGGCGACGA TCCATAGCTG GTCTGAGAGG
Patient 3 TGGTGAGGTA ACGGCTCACC AAGGCGACGA TCCATAGCTG GTCTGAGAGG
Patient 2 TGGTGAGGTA ACGGCTCACC AAGGCGACGA TCCATAGCTG GTCTGAGAGG
251 300
M73229 ATGATCAGCC ACACTGGGAC TGAGACACGG CCCAGACTCC TACGGGAGGC
Patient 1 ATGATCAGCC ACACTGGGAC TGAGACACGG CCCAGACTCC TACGGGAGGC
211684 ATGATCAGCC ACACTGGGAC TGAGACACGG CCCAGACTCC TACGGGAGGC
Patient 3 ATGATCAGCC ACACTGGGAC TGAGACACGG CCCAGACTCC TACGGGAGGC
Patient 2 ATGATCAGCC ACACTGGGAC TGAGACACGG CCCAGACTCC TACGGGAGGC
301 350
M73229 AGCAGTGGGG AATATTGGAC AATGGGGGCA ACCCTGATCC AGCCATGCCG
Patient 1 AGCAGTGGGG AATATTGGAC AATGGGGGCA A.CCTGATCC AGCCATGCCG
211684 AGCAGTGGGG AATATTGGAC AATGGGNGCA ACCCTGATCC AGCCATGCCG
Patient 3 AGCAGTGGGG AATATTGGAC AATGGGGGCA ACCCTGATCC AGCCATGCCG
Patient 2 AGCAGTGGGG AATATTGGAC AATGGGGGCA A.CCTGATCC AGCCATGCCG
351 400
M73229 CGTGAGTGAT GAAGGCCCTA GGGTTGTAAA GCTCTTTCAC CGGTGAAGAT
Patient 1 CGTGAGTGAT GAAGGCCCTA GGGTTGTAAA GCTCTTTCAC CGGTGAAGAT
211684 CGTGAGTGAT GAAGGCCCTA GGGTTGTAAA GCTCTTTCAC CGGTGAAGAT
Patient 3 CGTGAGTGAT GAAGGCCCTA GGGTTGTAAA GCTCTTTCAC CGGTGA
Patient 2 CGTGAGTGAT GAAGGCCCTA GGGTT
401 450
M73229 AATGACGGTA ACCGGAGAAG AAGCCCCGGC TAACTTCGTG CCAGCAGCCG
Patient 1 AATGACGGTA ACCGGAGAAG AAGCCCCGGC TAACTTCGTG C
Z11684 AATGACGGTA ACCGGAGAAG AAGCCCCGGC TAACTTCGTG CCAGCAGCCG
Figure 1 Alignment of partial 165 rRNA gene sequences of B. henselae. Gaps introduced for optimal alignment are
represented by a dot. Variable nucleotides are in bold.
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was found in the specimen which contained B. quintana
DNA. For the specimens with B. henselae DNA,
similarities between 98.7% and 99.7% were achieved
when compared to the two available B. henselae
reference sequences, M73229 and Z11684, respectively
(Table 1). Scoring results using the FASTA-opt
algorithm for the organisms most closely related to the
partial 16S rRNA sequence of patient 2 are listed in
Table 2; these indicate a strong association with the
genus Bartonella. Assignment to one particular species,
however, was not possible. Sequence heterogeneities
within the Bartonella sequences were assayed using the
PILEUP algorithm (Figure 1) and revealed not only the
same variations as recently described by Bergmans et a1.
(17) but also a one-base difference at position 50.
Sequence analysis of the reamplified material from
negative controls did not provide useful results in that,
at most, only very short stretches were readable. There
was some indication that these samples did not contain
a unique sequence but rather a mixture of sequences
(data not shown).
DISCUSSION
Four clinical specimens known to contain either B.
henselae or B. quintana DNA were analyzed with a
broad-range, 'eubacterial' PCR assay, targeting part of
the 16S rRNA gene, followed by direct sequencing of
the amplicon. The sequences obtained were nearly
identical to the reference sequences in GenBank and
EMBL databases, indicating a high reliability in the
sequencing method chosen. This was better than
expected, considering the extensive secondary structure
of 16S rRNA molecules and the fact that only one
sequencing reaction was performed per amplification.
In addition, sequencing accuracy was confirmed by
alignment of the partial 16S rRNA sequences derived
from the specimens which contained B. henselae. The
same intraspecies sequence variations that had pre-
viously been described by Bergmans et al. [17,18] were
detected (Figure 1). In addition, sequence variation
between the two published sequences and one of our
strains was also observed at position 50 (Figure 1).
Whether or not this variation results in the same
grouping ofstrains remains to be determined. The only
sequencing problem encountered was the reading of a
double C instead of a triple C at position 353 (E. coli
numbering) in two of the three B. henselae sequences.
As is typical for sequences derived directly from PCR-
amplified fragments, they contained neither poly-
merase-mediated errors nor non-specific masking
bands CN') [4].
In our experience, the result of the database search
was not as useful when using the normal FASTA
algorithm by GCG which scores according to initn
values as when using FASTA-opt. Interference was
especially observed with 16S rRNA sequences of
Rhizobium species. For example, analyzing the sequence
of patient 2 with the FASTA algorithm, Rhizobium loti
D12791 was found in the first position of the scoring
results, with 94.9% similarity and an irlitn score of971,
whereas the B. henselae reference sequence Z7329 was
only listed at the 13th position, with 99.3% similarity
and an initn score of936 (data not shown). In contrast,
using the FASTA-opt algorithm which scores accord-
ing to opt values, the B. henselae Z73229 and the R. loti
D12791 sequences were at the 1st and 16th position,
respectively, i.e. essentially according to similarity
values (Table 2).
Using the procedure described here, only about
300-400 nucleotides (i.e. about 20-25% of the
entire 16S rRNA genes) are determined. Despite this
limitation, the fragment sequenced could clearly be
assigned to the genus Bartonella, but not to one
particular species in the genus, because some of the
species (e.g. B. hmselae and B. grahamiz) are too closely
related to each other in those regions of their 16S
rRNA genes that are analyzed by our approach. This
does not significantly reduce the clinical utility of the
method, since treatment is usually the same for these
related organisms. For epidemiologic purposes, it may
be important to subsequently identify the infecting
organism to the species level; this can be accomplished
by using species-specific oligonucleotides for hybrid-
ization [4] or by designing species-specific amplification
systems based either on different regions of the 16S
rRNA gene or on targeting other genes [12,15].
The analysis of clinical material is extremely
sensitive to contamination. For this reason we use
dUTP instead of dTTP and uracil-DNA glycosylase
including a compatible DNA extraction method to
prevent product carryover from previous amplifications
[11,141. Reamplification was also done using dUTP;
in this case, however, no uracil-DNA glycosylase was
added, as this would have destroyed the products from
the first round of amplification. As shown here, the
dUTP-containing amplification product is entirely
compatible with the sequencing reaction in which
dTTP/ ddTTP is used.
In our application of the method, semi-nested
reamplification was necessary to increase the amount
of amplicon for the sequencing reaction. This should
not be done, however, before interpreting a result as
positive by agarose gel electrophoresis and/or after
hybridization (i.e. with a signal significantly above the
signal of the negative control), because reamplification
results in strong bands not only in truly positive samples
but also in negative controls. This may be due to some
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residual bacterial DNA in enzymes, primers or water
[14]. Furthermore, reamplification should also be done
with the incorporation of dUTP instead of dTTp,
because such amplicons would again be inactivated
during the amplification step by the uracil-DNA
glycosylase and should not cause any problems in future
analyses.
The method described here has also been used to
investigate bacterial 16S rRNA sequences of clinical
specimens which proved to contain pathogens such as
Staphylococcus, Propionibacterium, Streptococcus, Neisseria,
Kingella, Campylobacter and Borrelia spp. and the agent
of Whipple's disease, Tropheryma whippelii [19,20]
(unpublished observations). It minimizes pipetting steps
and eliminates time-consuming template purification
steps such as DNA precipitation or amplicon pre-
paration prior to sequencing, and this again reduces the
risk of carryover contamination. It profits from a
commercial sequencing kit with the advantage of a
permanent quality control. Reamplification of samples
previously judged positive usually resulted in a strong
specific band visible on agarose gels which was then
sequenced without problems. This indicates that
our method is highly sensitive, although the sensitivity
of species-specific peR systems that use smaller
amplicons is usually not achieved (data not shown).
We conclude that this method is a rapid, sensitive
and reliable tool for generating 16S rRNA sequences
directly from clinical material without the need to
culture the bacteria. It includes adequate measures for
preventing contamination as is required for diagnostic
purposes. Furthermore, this type of non-culture
approach has the potential to detect as yet unknown
bacteria in clinical specimens.
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